Lieming Ding
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 10%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Lung Cancer Treatments and Mutations 24
- Lung Cancer Diagnosis and Treatment 6
- Oncology 24
- HER2/EGFR in Cancer Research 7
- Colorectal Cancer Treatments and Studies 6
- Lung Cancer Research Studies 6
- Pancreatic and Hepatic Oncology Research 4
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Fenlai Tan (16 shared papers)Guojian Xie (2 shared papers)Xiaobin Yuan (7 shared papers)Yanping Wang (3 shared papers)Xiaoyan Shen (1 shared paper)Xiaodong Zhang (1 shared paper)Wei He (1 shared paper)Dechang Wang (1 shared paper)
- Journals
- Cancer Research (9 papers)Journal of Clinical Oncology (9 papers)Lung Cancer (3 papers)The Oncologist (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Lieming Ding
55 papers receiving 665 citations
Peers
Comparison fields: 5 of 63
- Pulmonary and Respiratory Medicine 318
- Oncology 235
- Cancer Research 41
- Molecular Biology 189
- Organic Chemistry 80
Countries citing papers authored by Lieming Ding
This map shows the geographic impact of Lieming Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lieming Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lieming Ding more than expected).
Fields of papers citing papers by Lieming Ding
This network shows the impact of papers produced by Lieming Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lieming Ding. The network helps show where Lieming Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Lieming Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 118 | |
| 2 | 2012 | 51 | |
| 3 | 2016 | 47 | |
| 4 | 2015 | 36 | |
| 5 | 2014 | 32 | |
| 6 | 2018 | 30 | |
| 7 | 2016 | 26 | |
| 8 | 2002 | 24 | |
| 9 | 2022 | 22 | |
| 10 | 2021 | 21 | |
| 11 | 2020 | 17 | |
| 12 | 2023 | 17 | |
| 13 | 2002 | 16 | |
| 14 | Potential predictive value of serum targeted metabolites and concurrently mutated genes for EGFR-TKI therapeutic efficacy in lung adenocarcinoma patients with EGFR sensitizing mutations. | 2020 | 14 |
| 15 | 2022 | 13 | |
| 16 | 2022 | 13 | |
| 17 | 2018 | 12 | |
| 18 | 2016 | 12 | |
| 19 | 2020 | 11 | |
| 20 | 2020 | 10 |
About Lieming Ding
Lieming Ding is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 57 papers that have together received 679 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (24 papers), HER2/EGFR in Cancer Research (7 papers), Lung Cancer Diagnosis and Treatment (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Lung Cancer Research Studies (6 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (318 citations), Oncology (235 citations), Cancer Research (41 citations), Molecular Biology (189 citations) and Organic Chemistry (80 citations). Lieming Ding has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Fenlai Tan, Guojian Xie, Xiaobin Yuan, Yanping Wang, Xiaoyan Shen, Xiaodong Zhang, Wei He, Dechang Wang, Shun Lü and Yuankai Shi. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Lung Cancer, The Oncologist and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.